Playback speed
10 seconds
Newest monarchE Trial Updates Including 5-Year Efficacy Outcomes - Adjuvant Abemaciclib + ET for HR+/HER2- High-Risk eBC
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Jens Huober
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Jens Huober
831 views
December 4, 2023
Login to view comments.
Click here to Login